Ambulatory Infusion Center Market Size 2024-2028
The ambulatory infusion center market size is forecast to increase by USD 14.69 billion at a CAGR of 5.6% between 2023 and 2028.
-
The market is witnessing significant growth due to the increasing prevalence of chronic inflammatory diseases such as hemophilia, congestive heart failure, multiple sclerosis, rheumatoid arthritis, and malnutrition. These conditions require regular intravenous administration of medications to manage symptoms and maintain patient health. As a result, ambulatory infusion centers offer a convenient and cost-effective alternative to hospital-based infusion therapy. A key trend in ambulatory centers is the increasing number of partnerships and acquisitions between healthcare providers and pharmaceutical companies to expand infusion center networks and offer comprehensive care to patients.
-
However, high costs associated with infusion therapy remain a significant challenge, as these centers require specialized equipment, trained staff, and ongoing maintenance. Safety precautions are also essential in ambulatory infusion centers to prevent complications such as dehydration, infection, and adverse reactions to medications. Overall, the market is poised for growth, driven by the increasing demand for convenient and cost-effective healthcare solutions for chronic conditions.
What will be the Size of the Ambulatory Infusion Center During the Forecast Period ?
- The healthcare industry is witnessing a significant shift towards ambulatory infusion centers as an effective solution for managing chronic diseases and providing long-term treatments. Infusion centers, a specialized type of healthcare facility, offer outpatient care for various medical conditions requiring frequent and prolonged infusions. Infusion therapies, such as IV infusions, photopheresis, chemotherapy, pain management, and targeted infusion therapy, play a crucial role in treating chronic diseases like cancer, Crohn's disease, cardiovascular diseases, diabetes, immune deficiencies, chronic inflammatory diseases, hemophilia, congestive heart failure, multiple sclerosis, rheumatoid arthritis, malnutrition, and dehydration.
- These conditions often necessitate regular and lengthy medical treatments, making ambulatory infusion centers an ideal choice for patients seeking patient-centered care. Infusion centers provide a more convenient and cost-effective alternative to traditional inpatient hospital stays. Patients can receive their treatments in a comfortable and familiar environment, reducing the stress and anxiety associated with lengthy hospital stays. Furthermore, these centers offer a more personalized care experience, allowing patients to work closely with their healthcare providers to manage their conditions effectively. Infusion centers are equipped with advanced infusion pumps and safety precautions to ensure the safe and efficient administration of drugs and other infusions.
How is this market segmented and which is the largest segment?
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
- Type
- Independent centers
- Hospitals
- Home healthcare
- Indication
- Oncology
- Autoimmune disorders
- Infectious diseases
- Neurological disorders
- Chronic pain conditions
- Geography
- North America
- Canada
- US
- Europe
- Germany
- UK
- France
- Spain
- Asia
- China
- India
- Japan
- South Korea
- Rest of World (ROW)
- North America
By Type Insights
- The independent centers segment is estimated to witness significant growth during the forecast period.
In the healthcare sector, ambulatory infusion centers have emerged as a critical segment, catering to the unique needs of patients requiring long-term infusion therapies. These centers offer outpatient care, providing an alternative to hospitalization for managing chronic conditions such as cancer and Crohn's disease. Independent ambulatory infusion centers, like the Independence Infusion Center, prioritize delivering safe and effective infusion therapies. Infusion therapies are administered using advanced infusion pumps, ensuring precise dosage and consistent delivery. The intravenous method of medication administration, via a sterile catheter, directly into the bloodstream, offers rapid and effective treatment.
Furthermore, this approach is particularly beneficial for patients with complex medical conditions, who may not respond well to oral medications or require alternative treatment modalities. Infusion therapies are essential for managing various chronic diseases, including cancer and Crohn's disease. The market is expected to grow significantly due to the increasing prevalence of chronic diseases and the rising demand for convenient, patient-centric healthcare solutions. These centers offer flexibility, allowing patients to receive treatment while maintaining their daily routines, ultimately improving their quality of life.
Get a glance at the market report of share of various segments Request Free Sample
The independent centers segment was valued at USD 18.63 billion in 2018 and showed a gradual increase during the forecast period.
Regional Analysis
- North America is estimated to contribute 53% to the growth of the global market during the forecast period.
Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
The market in North America is witnessing substantial growth, fueled by advancements in specialty pharmaceuticals and the increasing demand for medical treatment outside traditional hospital settings. This trend is particularly prominent in the United States and Canada, where healthcare providers are expanding the availability and quality of infusion therapies for lifestyle-related chronic disorders and genetic conditions.
This therapeutic injection, an approved form of Reglan, adds to the growing list of injectable medications for conditions like diabetic gastroparesis and postoperative nausea. This innovation not only enhances patient care but also underscores the growing reliance on ambulatory infusion centers for managing complex medical needs. Healthcare reforms and the shift towards patient-centered care have played a significant role in the growth of ambulatory infusion centers. These facilities offer convenience, cost savings, and improved patient outcomes, making them an attractive alternative to traditional inpatient care. As the prevalence of chronic disorders continues to rise, the market in North America is poised for continued expansion.
Market Dynamics
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
What are the key market drivers leading to the rise in adoption of Ambulatory Infusion Center Market?
Increasing investments is the key driver of the market.
- The market is witnessing substantial expansion due to escalating investments from diverse stakeholders. This trend is propelling the industry to broaden its scope and improve access to infusion therapy for individuals dealing with chronic health problems and immune deficiencies.
- Moreover, the funds will be allocated towards innovative technologies, such as smart pumps and advanced drug administration systems, which can optimize patient care and streamline services. Notably, these advancements are pivotal in the administration of complex therapies like Trastuzumab deruxtecan (T-DXd), ensuring optimal outcomes for patients. Thus, such factors are driving the growth of the market during the forecast period.
What are the market trends shaping the Ambulatory Infusion Center Market?
Partnerships and acquisitions is the upcoming trend in the market.
- The market is experiencing significant growth through strategic partnerships and acquisitions. In a recent development, Elevance Health announced its acquisition of Paragon Healthcare, a prominent player offering infusible and injectable therapies. With a two-decade track record, Paragon Healthcare operates an omnichannel model, encompassing ambulatory infusion centers and home infusion pharmacies.
- This acquisition is aimed at leveraging Paragon's well-established infrastructure and expertise in delivering high-quality care for various chronic and acute conditions. This consolidation aims to expand Access Infusion Care's reach and capabilities, enabling it to provide advanced medical procedures and specialized therapies in a more efficient and effective manner.
What challenges does Ambulatory Infusion Center Market face during its growth?
High costs associated with infusion therapy is a key challenge affecting the market growth.
- Balancing Effectiveness and Affordability Infusion therapy, a critical treatment method for managing chronic diseases such as hemophilia, congestive heart failure, multiple sclerosis, rheumatoid arthritis, and others, is administered through intravenous infusion.
- This approach offers numerous benefits, including improved patient outcomes, increased convenience, and reduced hospital stays. However, the market faces significant challenges related to the high costs associated with this therapy. Hence, the above factors will impede the growth of the market during the forecast period.
Exclusive Customer Landscape
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Ameripharma Infusion Center
- Arnot Health
- Carson Tahoe Health
- ChristianaCare
- Coram llc
- Haywood Regional Medical Center
- Horizon Infusions
- Icahn School of Medicine at Mount Sinai
- Novant Health
- Palmetto Infusion
- Premier Point
- Stoughton Health
- Swedish Health Services
- ThrivewellI
- United Health Group Inc.
- Valley Health System
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Research Analyst Overview
Ambulatory infusion centers have emerged as a significant healthcare trend, offering long-term treatment solutions for various chronic diseases. These centers specialize in infusion therapies, including IV infusions, photopheresis, and targeted infusion therapies, for conditions such as cancer, Crohn's disease, diabetes, cardiovascular diseases, autoimmune disorders, and chronic inflammatory disorders. Infusion pumps play a crucial role in delivering these therapies, ensuring precise dosages and safety. Chronic diseases like oncology, immune deficiencies, hemophilia, congestive heart failure, multiple sclerosis, rheumatoid arthritis, malnutrition, and dehydration are some of the common indications for ambulatory infusion therapy.
Furthermore, patient-centered care is a priority in these centers, providing advanced medical procedures and specialized therapies, including biologics, monoclonal antibodies, gene therapies, and blood product infusions. Safety precautions are rigorously followed to minimize adverse reactions, patient fear, and surgical burden. Hospital-affiliated centers, clinics, and home health agencies collaborate to offer comprehensive care, while medical tourism and specialty pharmaceuticals contribute to the market's growth. Healthcare reforms and lifestyle-related chronic disorders further fuel the demand for ambulatory infusion centers. Smart pumps, microport lifesciences, and other medical equipment suppliers cater to the growing needs of these centers, ensuring efficient and effective drug administration.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
207 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 5.6% |
|
Market Growth 2024-2028 |
USD 14.69 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
5.0 |
|
Key countries |
US, UK, China, Germany, Japan, France, Spain, South Korea, Canada, and India |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
What are the Key Data Covered in this Market Research and Growth Report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
- Precise estimation of the size of the market and its contribution of the market in focus to the parent market
- Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market's competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the growth of market companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
RIA - 
